Metraipolis › archive › dc_37cd2e44e9d3

MR-Linac-Based SBRT for Prostate Cancer: Dosimetric Benefits for Urethral Sparing Compared to VMAT and Tomotherapy — Europe PMC PMID:41749821

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41749821
DOI
10.3390/cancers18040568
License (as archived)
solo-consultazione
Archived
2026-11-06T00:43:17.581Z
SHA-256 of the archived text
0d06f8f4f908fe27e933c813992233b8ac62ed5ce58e9b81113538df973a76df
Stable URL of this page
https://metraipolis.com/documento/dc_37cd2e44e9d3

How to cite

MR-Linac-Based SBRT for Prostate Cancer: Dosimetric Benefits for Urethral Sparing Compared to VMAT and Tomotherapy — Europe PMC PMID:41749821 — Europe PMC (en), https://europepmc.org/article/MED/41749821 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_37cd2e44e9d3 (Metraipolis archive dc_37cd2e44e9d3, sha256 0d06f8f4f908fe27e933c813992233b8ac62ed5ce58e9b81113538df973a76df)
BibTeX
@misc{dc37cd2e44e9d3,
  title = {MR-Linac-Based SBRT for Prostate Cancer: Dosimetric Benefits for Urethral Sparing Compared to VMAT and Tomotherapy — Europe PMC PMID:41749821},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41749821},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_37cd2e44e9d3; sha256 0d06f8f4f908fe27e933c813992233b8ac62ed5ce58e9b81113538df973a76df},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41749821. Agents can read the archived copy with the MCP tool read_document.